Written by Sophie Vergnaud, MD | Reviewed by Alyssa Billingsley, PharmDPublished on May 3, 2024 Key takeaways: Tirzepatide (Zepbound) isn’t currently approved for the treatment of obstructive sleep apnea (OSA), but it could be as early as the end of 2024.People who could potentially benefit from the medication for OSA may already be eligible for...
Tag: <span>obstructive sleep apnea</span>
Continuous positive airway pressure therapy in patients with coronary artery disease and obstructive sleep apnea
by Compuscript Ltd Credit: Pixabay/CC0 Public DomainObstructive sleep apnea (OSA) is highly common in patients with coronary artery disease (CAD) and it is a strong predictor of subsequent cardiovascular events. However, whether treatment with continuous positive airway pressure (CPAP) can decrease this risk remains controversial. PubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were systematically searched...
How might obstructive sleep apnea heighten cardiovascular risk?
Lower blood oxygen levels due to sleep apnea may explain the higher cardiovascular risk faced by people with this condition. Image credit: milorad kravic/Getty Images. A new study finds that reduced blood oxygen levels may be a leading factor behind the link between obstructive sleep apnea and increased cardiovascular risk. Researchers reviewed data from more...
Obstructive sleep apnea puts a strain on the heart, too
UNIVERSITY OF EASTERN FINLAND IMAGE: DATA AVAILABLE FROM CLINICAL SLEEP STUDIES COULD BE UTILISED MORE EXTENSIVELY BY, FOR EXAMPLE, PAYING CLOSER ATTENTION TO HEART RATE AND HEART RATE VARIABILITY. CREDIT: UEF / RAIJA TÖRRÖNEN Longer nocturnal respiratory events in patients with obstructive sleep apnoea (OSA) cause higher immediate heart rate variability, and greater changes in...
Obstructive sleep apnea risk varies in patients with different types of epilepsy
RUTGERS UNIVERSITY People with generalized epilepsy who have seizures arising from both sides of the brain simultaneously, have a higher risk of obstructive sleep apnea (OSA) compared to patients who have focal epilepsy where seizures emanate from one area of the brain, according to a Rutgers study. The study, published in the October issue of...
Treating Excess of One Hormone Shows Promise for Decreasing the Risk of Obstructive Sleep Apnea
Treating the overproduction of one hormone may be a way to help a subset of the millions of Americans who suffer from obstructive sleep apnea, according to a new study. People with obstructive sleep apnea stop breathing for short periods while they are sleeping, which leads to a poor night’s sleep and debilitating fatigue during the day. Most people with the condition need to use dental devices or...
Dietary supplement derived from tree bark shows promise for treating obstructive sleep apnea
Obstructive sleep apnea is caused by a narrowing of the airway that cuts off breathing, and people who are obese are at higher risk for the disorder. MIT researchers have discovered that a dietary supplement called yohimbine reverses the …more Obstructive sleep apnea, which causes people to briefly stop breathing while asleep, affects an estimated...
Apnea app spares the sensors
An experimental new app is designed to diagnose obstructive sleep apnea(Credit:monkeybusiness/Depositphotos) When doctors are trying to determine if someone has obstructive sleep apnea (OSA), they often get that person to sleep overnight in a lab while wired up to a variety of sensors. Known as polysomnography (PSG), this process records the patient’s brain waves,...